Biolase Profit Margin 2006-2018 | BIOL

Current and historical gross margin, operating margin and net profit margin for Biolase (BIOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biolase net profit margin as of September 30, 2018 is -40.31%.
Biolase Annual Profit Margins
Biolase Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $0.047B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.940B 22.07
McKesson (MCK) United States $24.748B 9.45
Align Technology (ALGN) United States $17.604B 44.92
AmerisourceBergen (ABC) United States $16.925B 12.32
Cardinal Health (CAH) United States $14.614B 9.81
Laboratory Of America Holdings (LH) United States $13.894B 12.57
Cooper (COO) United States $13.274B 23.41
Henry Schein (HSIC) United States $12.088B 19.88
DENTSPLY SIRONA (XRAY) United States $9.087B 18.15
West Pharmaceutical Services (WST) United States $7.797B 38.69
Merit Medical Systems (MMSI) United States $2.939B 34.81
Patterson (PDCO) United States $2.117B 16.15
CONMED (CNMD) United States $1.874B 31.14
STAAR Surgical (STAA) United States $1.552B 159.82
Atrion (ATRI) United States $1.419B 40.56
Antares Pharma (ATRS) United States $0.484B 0.00
Lifevantage (LFVN) United States $0.205B 29.06
Invacare (IVC) United States $0.158B 0.00
Endologix (ELGX) United States $0.086B 0.00
Pro-Dex (PDEX) United States $0.057B 25.26
Aceto (ACET) United States $0.043B 0.00